ABIONYX Pharma SA (EPA:ABNX)
2.220
-0.010 (-0.45%)
Jun 23, 2026, 5:35 PM CET
ABIONYX Pharma Employees
ABIONYX Pharma had 49 employees as of December 31, 2025. The number of employees decreased by 2 or -3.92% compared to the previous year.
Employees
49
Change (1Y)
-2
Growth (1Y)
-3.92%
Revenue / Employee
€82,918
Profits / Employee
€113,265
Market Cap
78.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 49 | -2 | -3.92% |
| Dec 31, 2024 | 51 | -10 | -16.39% |
| Dec 31, 2023 | 61 | -2 | -3.17% |
| Dec 31, 2022 | 63 | 1 | 1.61% |
| Dec 31, 2021 | 62 | 59 | 1,671.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Innate Pharma | 164 |
| Transgene | 145 |
| Adocia | 73 |
| OSE Immunotherapeutics | 64 |
| Sensorion | 63 |
| Fermentalg | 63 |
| MaaT Pharma | 59 |